PNC Financial Services Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Buy |
11,219
+1,619
| +17% | +$52.6K | ﹤0.01% | 1782 |
|
|
2025
Q1 | $362K | Buy |
9,600
+524
| +6% | +$19.8K | ﹤0.01% | 1757 |
|
|
2024
Q4 | $743K | Buy |
9,076
+1,397
| +18% | +$114K | ﹤0.01% | 1300 |
|
|
2024
Q3 | $877K | Sell |
7,679
-765
| -9% | -$87.4K | ﹤0.01% | 1232 |
|
|
2024
Q2 | $638K | Buy |
8,444
+1,080
| +15% | +$81.6K | ﹤0.01% | 1362 |
|
|
2024
Q1 | $503K | Buy |
7,364
+378
| +5% | +$25.8K | ﹤0.01% | 1531 |
|
|
2023
Q4 | $439K | Buy |
6,986
+1,411
| +25% | +$88.6K | ﹤0.01% | 1605 |
|
|
2023
Q3 | $284K | Buy |
5,575
+5,119
| +1,123% | +$261K | ﹤0.01% | 1869 |
|
|
2023
Q2 | $22.8K | Buy |
456
+339
| +290% | +$16.9K | ﹤0.01% | 3493 |
|
|
2023
Q1 | $4.39K | Sell |
117
-6
| -5% | -$225 | ﹤0.01% | 4082 |
|
|
2022
Q4 | $5.9K | Buy |
123
+23
| +23% | +$1.1K | ﹤0.01% | 3941 |
|
|
2022
Q3 | $2K | Sell |
100
-6
| -6% | -$120 | ﹤0.01% | 4201 |
|
|
2022
Q2 | $2K | Buy |
+106
| New | +$2K | ﹤0.01% | 4230 |
|